BOSTON SCIENTIFIC BUYS LEADERSHIP POSITION IN INTERVENTIONAL NEURORADIOLOGY WITH $1.1 BIL. TARGET MERGER; STOCK DEAL RESOLVES COMPANIES' PATENT DISPUTE